• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Matrix metalloproteinase-27 (MMP27)

ACP11545

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP11545 Target NameMMP27
Target SynonymsEC 3.4.24.; Matrix metallopeptidase 27; Matrix metalloprotease 27; Matrix metalloproteinase 27 ; Matrix metalloproteinase-27; MMP 27; MMP-27; MMP27; MMP27_HUMANFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range99-513
Protein LengthFull Length of Mature ProteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9H306
Background Information
  • Uniprot Id

    Q9H306

  • Target Species

    Human

  • Target Name

    MMP27

  • Target Full Name

    Matrix metalloproteinase-27

  • Target Function

    Matrix metalloproteinases degrade protein components of the extracellular matrix such as fibronectin, laminin, gelatins and/or collagens.

  • Target Subcellular Location

    Endoplasmic reticulum membrane; Peripheral membrane protein.

  • Target Protein Families

    Peptidase M10A family

  • Target Tissue Specificity

    Expressed in B-cells. Expressed in a subset of endometrial macrophages related to menstruation and in ovarian and peritoneal endometriotic lesions (at protein level)(PubMed:24810263).

  • Target Synonyms

    EC 3.4.24.; Matrix metallopeptidase 27; Matrix metalloprotease 27; Matrix metalloproteinase 27 ; Matrix metalloproteinase-27; MMP 27; MMP-27; MMP27; MMP27_HUMAN

Inquire Recombinant Human Matrix metalloproteinase-27 (MMP27) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification